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2Abstract
Purpose: The aim of this cohort study was to evaluate the value of
echocardiographic multilayer strain analysis in the identification of arrhythmogenic
cardiomyopathy (AC) in its earliest stages in which sudden cardiac death can occurs.
Methods and Results: Twenty seven asymptomatic relatives of AC probands
(mean age 39.6±19.5 years, 37% male) with a desmosomal pathogenic mutation but
no additional criteria for AC (group II) were compared to age and sex-matched
healthy controls (group I). In addition, 70 patients harboring a pathogenic
desmosomal mutation with “definitive” diagnosis of AC (group IV), and 19 subjects
with “borderline” diagnosis (group III) were also studied. A standard
echocardiographic evaluation plus left (LV) and right ventricular (RV) global and
regional transmural, endocardial, and epicardial longitudinal strain (LS) analysis, was
performed. In group II, while LV ejection fraction, fractional shortening, and S’ were
not significantly reduced compared to controls, transmural global LS was significantly
reduced to 19.3±1.8% in group II vs. 20.9±1.1% in controls (p=0.0003). Compared to
controls, group II presented significant (p<0.05) regional LS decrease in the basal
infero-lateral, antero-lateral, latero-apical, infero-septal, and septo-apical segments.
Moreover, LS of the latero-apical and the basal antero-lateral segments was
significantly altered in the epicardium (p<0.05) but not significantly in the
endocardium.
Conclusions: Global and regional LV LS analysis allows detection of AC in an early
or non-diagnostic stage of the disease. Moreover, epicardial LS analysis allows the
detection of abnormalities earlier than endocardial LS.
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Abbreviation List
AC = arrhythmogenic cardiomyopathy
CMR = cardiovascular magnetic resonance
EF = ejection fraction
LV = left ventricle
LGE = late gadolinium enhancement
LS = longitudinal strain
ROC = receiver operating characteristics
RV = right ventricle
TFC = Task Force Criteria
4Introduction
Arrhythmogenic cardiomyopathy (AC) is a genetic disease of the desmosome which
is characterized by ventricular arrhythmias and myocardial dysfunction. Often both
right ventricular (RV) and left ventricular (LV) myocardium are involved [1].
In AC, sudden cardiac death often occurs in the concealed phase in asymptomatic
subjects when no or only subtle signs of the disease are observed [2]. The diagnosis
is currently made on the presence of major and minor Task Force Criteria (TFC) that
include structural, functional, anatomical, histological, electrocardiographic,
arrhythmic, and genetic factors. Current guidelines recommend that all patient’s first
degree relatives with AC undergo ECG, echocardiography, and screening of the
pathogenic gene mutation when identified [3]. Since sudden death may occur in the
absence of current TFC there is a strong need to develop novel diagnostic methods
to identify the disease.
Speckle-tracking strain analysis by echocardiography is well recognized now to allow
easily early detection of LV longitudinal contractility abnormalities while ejection
fraction (EF) is still preserved in various pathologies (e.g hypertrophic
cardiomyopathy, cardiac amyloidosis, severe asymptomatic aortic valve stenosis)[4-
6].
A recent development of this tool called “multilayer strain analysis” allows analyzing
separately both the endocardial and the epicardial half part of the myocardial wall [7-
9]. The aim of this cohort study was to evaluate the additional value of endo- and
epicardial speckle-tracking deformation analysis to detect early subclinical LV and
RV function abnormalities in asymptomatic carriers of pathogenic AC desmosomal
mutations.
5Methods
This was an observational single-centre cohort study performed in the specialized
Inherited Heart Disease Unit at The Heart Hospital, London, United Kingdom. We
studied the cohort of AC attending from August 2009 to May 2014. All consecutive
patients were eligible for the study.
The study inclusion criteria were patients aged ≥12 years with diagnosis of AC 
based on 2010 TFC, or their relatives who carried the same pathogenic desmosomal
AC mutation but did not fulfill diagnostic criteria [3].
Exclusion criteria were as follows: (1) permanent or persistent atrial fibrillation
at the study visit; (2) poor echocardiographic image quality (inability to perform strain
analysis due to poor echo window (more than 3 LV segments not correctly visualized
or, non accurate tracking or reverberation artefacts); (3) concomitant pathologies
known to impair longitudinal contraction (e.g. diabetes, myocardial infarction,
hypertension).
Demographic characteristics were collected from the hospital records at the
time of echocardiography. Cardiovascular magnetic resonance (CMR) analysis of
late gadolinium enhancements (LGE) was analyzed when CMR was performed
within less than 12 months compared to the reference echocardiography.
Patients were diagnosed with AC based on fulfillment of the TFC of the
current guidelines [3]. All individuals in groups II, III, and IV carried at least one
pathogenic desmosomal mutation. Group IV consisted of patients with “definitive” AC
diagnosis according to TFC 2010 (2 major criteria or 1 major and 2 minor criteria or 4
minor criteria from different categories). Group III consisted of patients with
6“borderline” AC diagnosis according to TFC 2010 (1 major and 1 minor criterion or 3
minor criteria from different categories). Group II consisted of relatives of AC patients
that only carried at least one pathogenic desmosomal mutation consequently fulfilling
the definition of a “possible” diagnosis of AC (=1 major criterion). Healthy volunteers
were recruited as controls (group I). All were asymptomatic and lacked family history
of premature cardiovascular disease. No one was on cardiac medication. All
participants gave informed consent conforming to the Declaration of Helsinki.
The echocardiography protocol was based on standardized acquisitions in all
patients attending the clinic [10]. Resting two-dimensional echocardiography was
performed according to American Society of Echocardiography guidelines [10,11],
with a Vivid 7 or E9 machine equipped with a M3S transducer (General Electric
Medical System®, Horten, Norway). Recordings in standardized views were
acquired in two-dimensional, M-mode, pulsed Doppler, continuous Doppler, color
Doppler, and pulsed tissue Doppler imaging modalities, and digitally stored for
subsequent off-line analysis on a dedicated workstation (Echopac® software version
BT11.3 (General Electric Medical System®, Horten, Norway). One independent and
experienced observer (P.R.), blinded to the patient’s history, analyzed all the
echocardiograms, applying standard measurements according to European
Association of Echocardiography/American Society of Echocardiography guidelines
[10,11]. LV volumes and LVEF were calculated using biplane Simpson’s rule [10].
Biplane maximal left atrial volume was calculated using the area-length method, and
then was indexed to body surface area. LV filling pressures were estimated using
pulsed Doppler mitral inflow and the ratio of peak E wave over E’ on tissue Doppler
imaging at the lateral side of the mitral annulus. RV measurements were performed
as previously described [12,13]. RV end-diastolic and end-systolic areas were used
7to calculate the RV fraction of area change (in %) using a modified 4-chamber view
focused on the RV. RV outflow tract diameter was measured in parasternal short
axis view. The presence of RV akinesia, dyskinesia, or aneurysm was qualitatively
appreciated. Tricuspid annular plane systolic excursion was measured as well as S’
peak longitudinal systolic velocity by tissue Doppler imaging, at the basal lateral RV
free wall. Pulmonary artery systolic pressure was measured according to the
guidelines [13]. Left ventricular longitudinal strain (LS) was quantified in the three
apical views using the two-dimensional speckle-tracking echocardiographic method
[4,14]. The frame rate of the recordings was between 45 and 75 ips. GLS was
presented in magnitude throughout the manuscript. Transmural end-systolic peak
values of LS were recorded in a 17 segments model and global LS was calculated
as the mean of the 17 segments. The region of interest was manually set to ensure
an accurate covering of the myocardial wall. The software automatically split the LV
wall region of interest in two equal half parts: endocardial, and epicardial given
endocardial and epicardial LS for each of the 17 segments. For the RV, the same
analysis was performed for the 3 lateral free wall segments (using the 4 chamber
view; basal, mid and apical segments) when the image was considered of sufficient
quality to allow accurate tracking. RV strain analysis was considered accurate and
performed when wall thickness was totally visualized from endocardium to
epicardium.
CMR scan with LGE was performed when clinically indicated. Standard
clinical scans (localizers, 3 long-axis views, black and white blood images, full LV
short-axis stack) were performed using a 1.5-T magnet (Avanto, Siemens Medical
Solutions, Erlangen, Germany). CMR short-axis volumetric studies [15] were
acquired from retrospectively gated, breath-held, balanced, steady-state free-
8precession cines (slice thickness, 7.0 mm; interslice gap, 3.0 mm; flip angle, 60°–
80°; repetition time, 3.0 ms; echo time, 1.33 ms; field of view read typically, 380 mm;
phase resolution, 75%; typical acquired voxel size, 1.5×1.7 mm; lines per segment).
Breath-held, LGE images acquired through an inversion recovery turbo fast low-
angle shot sequence were obtained 7 to 15 minutes after injection of 0.1 mmol/kg
gadolinium-diethylenetriamine penta-acetic acid. For the purpose of this study, the
presence of LGE and the structure of the LV were evaluated retrospectively by
cardiologists experienced in CMR (S.C. and J.C.M.) on CMR scans which were
performed within 12 months of the echocardiography. For each of the 17 segments,
endocardial and epicardial parts of the myocardial wall were coded according to
presence or absence (1 or 0) of LGE.
All statistical analyses were performed using SPSS® (Version 17.0, SPSS
Inc., Chicago, IL, USA). Continuous variables were expressed as mean±SD or
median (IQR), and categorical variables as frequencies and percentages.
Comparison between groups I and II continuous variables were performed using an
unpaired student t test. For comparison between the 4 groups, an Anova one-way
test was performed. Receiver Operating Characteristics curve was performed to
assess the relation between LS and presence of LGE, and to determine optimal cut-
off value of LV LS to predict presence of LGE. Our methods comply with the
STROBE statement [16]. P values were two-sided, and a p value ≤0.05 was 
considered statistically significant.
To assess intraobserver variability, data from 16 subjects were analyzed twice
offline by the same operator (P.R.), with at least 1 week-interval between the two
analyses. A second observer (A.H.) blinded to the results of the preceding
investigations similarly performed the 16 analyses in order to assess interobserver
9variability. Variability was expressed as percentage. Percentage of variability was
calculated as the absolute difference divided by the average of the two
measurements of the same dataset. This was performed for global and regional
analysis of both the LV and RV, on a transmural basis as well as for endocardial
strain and epicardial strain.
Results
Among 131 mutation carrier patients (2006-2012), 2 were excluded because of
permanent atrial fibrillation, and 13 were excluded due to inability to record LV strain
analysis as a consequence of insufficient image quality.
Accordingly, data from 142 subjects were finally analyzed: 70 patients with
“definitive” diagnosis of AC (group IV), 19 patients with “borderline” diagnosis (group
III), 27 asymptomatic carriers of a pathogenic desmosomal mutation with
consequently “possible” diagnosis of AC (group II, mean age of 39.6±19.5 years,
37% male), and 26 healthy controls (group I, mean age 38.7±11.4 years, 38% male).
The demographics, clinical and main echocardiographic characteristics of the
population are presented in Table 1. Although normal in some cases, mean of all RV
systolic function parameters were significantly altered in groups III and IV compared
to controls (group I) but only tricuspid annular plane systolic excursion, S’ by tissue
Doppler imaging, and global RV strain were significantly altered in group II compared
to controls (transmural RV LS was 26.8±5.1% in group II vs. 31.0±4.2% in controls,
p=0.005). Table 2 shows results at RV basal, mid and apical level in the four groups.
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The LVEF was relatively preserved in all TFC groups while LV GLS was
significantly impaired in group II compared to controls (19.3±1.8% vs. 20.9±1.1%,
p=0.0003)(Table 1).
Feasibility of strain analysis on the RV was 75% (319/426 segments correctly
tracked), and 94% on the LV (2271/2414 segments correctly tracked).
Left ventricular regional strain analysis (Figures 1, 2, 3) showed significant
abnormalities located particularly in the infero-lateral, antero-lateral, and infero-septal
walls in group II compared to controls (p<0.05). However, LS of the latero-apical and
the basal antero-lateral segments were significantly altered only in the epicardium
(Figure 3) but not in the endocardium (Figure 2). In this study, if we consider a value
of <17% for abnormal LV regional longitudinal strain [4], 18 (67%) over 27
desmosomal-gene mutation carriers had at least 3 abnormal regional strain values
(vs 19% of the controls).
Table 3 depicts the relatively good intra- and inter-observer reproducibilities
for global LV LS (variability between 3.1% to 6.1%) and RV strain analyses (between
6.1% and 11.9%), transmural as well as endocardial and epicardial analyses.
Variability was relatively higher for regional analysis (between 7.8% and 11.5% for
mean intraobserver analysis, and between 9.7% and 13.0% for interobserver
analysis).
CMR scans performed at <12 months of the echocardiography was available
for retrospective analysis for 28 AC patients (19 of the group IV, 3 of the group III,
and 6 of the group II). This corresponds to 578 half LV segments analyzed. Figure 4
displays the receiver operating characteristics (ROC) curve analysis of regional LS
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analysis to predict presence of LGE. AUC was 0.69 (95% CI = 0.63-0.75) with the
best cut-off value of LS≤17.5% giving a sensitivity of 72%, and specificity of 57%. 
Discussion
This study is the first to have investigated regional endo- vs. epicardial longitudinal
LS analysis by speckle-tracking echocardiography in both LV and RV in AC patients
and in desmosomal mutation carriers compared to healthy controls. This analysis
highlights LV longitudinal regional epicardial strain alteration to be more sensitive
than endocardial strain in identifying early LV contraction abnormalities. Epicardial
strain was particularly altered in the latero-apical and in the basal antero-lateral
segments in AC relatives who carry a pathogenic desmosomal mutation, but did not
show other signs of AC; RV longitudinal strain was also impaired in these patients,
particularly in the mid lateral segment.
Arrhythmogenic cardiomyopathy is a diffuse and progressive heart muscle
disease predominantly involving the free wall of the RV in which the myocardium is
replaced by fatty and fibro-fatty tissue. Although the disease is more often
recognized in the RV presenting structural and functional abnormalities, the LV is
also affected in many cases [1,17]. In one autopsy study, LV involvement was found
in up to 76% of 42 subjects who died suddenly or were explanted with a pathological
diagnosis of AC [1].
The presence of a pathogenic desmosomal mutation detected in a first degree
relative of a patient with AC is considered in itself as one major criterion for AC. If
imaging modalities (echocardiography or CMR) detect one minor criterion, the
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diagnosis is “borderline”. If one additional minor or major criterion is identified, the
diagnosis of AC is “definitive” [3]. CMR is a valuable imaging technique for detecting
abnormalities in AC: abnormal RV free wall morphology (focal aneurysms), wall
motion abnormalities, global ventricular dilatation, presence of fatty infiltration that
can be suppressed in fat suppression sequences, or myocardial fibrosis (LGE) which
often co-exists in the fat-infiltrated RV myocardium [18-20]. The presence of LGE is
also a predictor of inducible ventricular tachycardia on electrophysiological studies
[18]. However, for either screening a large group of subjects or for the detection of
early disease, a CMR examination may not be the technique of choice. Detection of
RV wall motion abnormalities by echocardiography, if shown to be sufficiently
sensitive and specific, could be a more appropriate imaging approach because of its
availability and lower costs. According to 2010 revised TFC [3], a minor criterion of
AC is present if echocardiography detect regional RV akinesia, dyskinesia, or
aneurysm, and 1 of the following (end-diastolic measurements):
— parasternal long axis RV outflow tract diameter ≥29mm to <32mm (≥16mm/m² to 
<19mm/m²)  [major criteria if ≥32 mm (≥19 mm/m²)]  
— parasternal short axis RV outflow tract diameter ≥32mm to <36mm (≥18mm/m² to 
<21mm/m²)  [major criteria if ≥36 mm (≥21 mm/m²)] 
— or RV fractional area change >33% to ≤40% [major criteria if ≤33%] 
However, at early stages of the disease visual detection of wall motion abnormalities
is challenging regardless of the technique applied (echo or CMR). As longitudinal
dysfunction precedes wall motion abnormalities and EF impairment in various
cardiomyopathies, if wall motion abnormalities are absent, evaluation of longitudinal
function could be very helpful and more sensitive [21]. Tissue Doppler imaging has
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been shown to enable quantitative assessment of RV function and the detection of
AC [22]. However, this technique is subject to some limitations such as Doppler
angle dependency particularly at mid and apical segments.
Strain analysis has previously demonstrated the capability to detect both early
LV and RV LS abnormalities in AC mutation carriers without RV wall motion
abnormalities. Teske et al showed a high feasibility of speckle-tracking
echocardiographic measurements in AC patients [23,24]. Fourteen asymptomatic
first-degree relatives of AC probands with a pathogenic plakophilin-2 mutation were
compared to healthy controls [24]. RV dimensions in the AC relative group were
similar to those in controls and global systolic parameters were moderately reduced
(tricuspid annular plane systolic excursion was altered significantly but not RV
fractional area change). Doppler tissue imaging and speckle-tracking strain (and
strain rate) values were reduced in the AC mutation carriers group in the basal and
mid RV segments compared with controls (p<0.001). In this study, a cut-off of 18%
was used to define abnormal RV strain. According to recent international guidelines,
normal values for RV strain are 29.0 ± 4.5% [25] and 28.3 ± 8.2% in a recent study
[26], and strain of the RV free wall is considered abnormal when <20.0% [25]. In
another recent study, 19 male first degree relatives of patients with definitive
diagnosis of AC were compared to 22 healthy volunteers [27]. Speckle-tracking was
feasible for both ventricles in AC patients, relatives and controls. However, LS was
analyzed only for two LV segments (basal and mid level segments of the lateral
wall), and four RV segments (basal and mid level segments of the lateral RV free
wall, and basal and mid level segments of the septal wall). Only basal septum LS
was significantly lower in relatives compared to controls (15.8% vs 17.8%, p=0.025)
[27]. Our study investigated LV regional and global strain abnormalities in a 17
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segments model while only 2-4 LV segments were analyzed in this previous cited
study. In addition, we analyzed LS transmurally with specific endocardial and
epicardial measurements using dedicated software. The ability to differentiate here
myocardial layers (endocardium and epicardium parts) is particularly relevant as it is
well recognized that disease involvement frequently begins in the epicardium with
the endocardial involvement developing at a later stage [20]. In our study, while
LVEF, fractional shortening, and S’ by tissue Doppler imaging were not significantly
reduced compared to controls, transmural global LV LS was significantly reduced in
desmosomal mutation carriers compared to controls (p=0.0003). Compared to
controls, group II presented significant regional LS alterations particularly in the
infero-lateral, antero-lateral, and infero-septal walls (p<0.05). In addition, compared
to controls, LS of the latero-apical and the basal antero-lateral segments were
significantly altered only in the epicardium while endocardial LS was not, consistent
with early detection of disease.
The strength of this single centre large cohort study is it systematically
investigated LV regional and global myocardial strain abnormalities in a 17 segments
model, and then separating epicardial and edocardial wall parts. Follow-up will be
useful to confirm that LS (epicardial ± endocardial strain) regional abnormalities
precede or predict the subsequent development of overt stages of the disease.
Consistent with this hypothesis is the finding that ROC curves demonstrated that LS
>17.5% predicted the presence of LGE. However, in clinical use, it is important to
keep in mind that several factors such as ethnicity, age, diabetes, myocardial
ischemia, and hypertension might reduce LS and should be taken in account for
careful interpretation of the data. There are also some limitations. We acknowledge
that the choice of a LS cut-off value was based on the little data available. Although
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LS measurements have previously been described as concordant when compared to
another vendor, the use of cut-off values has not been tested when using different
devices [28].
In clinical practice, global and regional LV strain with endocardial and
epicardial analysis could be performed easily at the bedside in less than 3 min, with
good intra- and interobserver reproducibility. Larger and multicentre studies will be
needed to confirm these findings and evaluate the clinical diagnostic utility of LV
strain measurements, as well as their predictive value for ventricular arrhythmia and
heart failure outcomes.
Conclusions
Global and regional LV LS analysis allows detection of AC at a very early stage in
mutation carriers when other parameters of LV systolic function are apparently still
normal. Moreover, epicardial LS analysis allows a better detection of abnormalities
earlier than endocardial LS.
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Figures Legend
Figure 1: Transmural LV LS in group II vs. controls: regional analysis;
significant alteration of LS in the basal infero-septal, mid infero-septal, septo-apical,
latero-apical, basal infero-lateral, mid antero-lateral, and basal antero-lateral
segments (total = 7 segments, pink color). Values are expressed in %.
Figure 2: Endocardial LV LS in group II vs. controls: regional analysis;
significant alteration of LS in the basal infero-septal, mid infero-septal, septo-apical,
basal infero-lateral, and mid antero-lateral segments (total = 5 segments, pink color).
Values are expressed in %.
Figure 3: Epicardial LV LS in group II vs. controls: regional analysis; significant
alteration of LS in the basal infero-septal, mid infero-septal, septo-apical, latero-
apical, basal infero-lateral, mid antero-lateral, and basal antero-lateral segments
(total = 7 segments, pink color). Values are expressed in %.
Figure 4: Receiver operating characteristics curve analysis of regional LS
analysis to predict presence of LGE.
Table 1: Baseline clinical, demographic and main echocardiographic
characteristics of the population
Parameters
Group IV
(N=70)
Group III
(N=19)
Group II
(N=27)
Group I
(N=26)
p value
group I
vs II
p value
Anova
Male gender―no. (%) 35 (49) 10 (53) 10 (37) 10 (38) 0.91 0.59
Age (years) 46.6 ± 14.2 44.8 ± 18.7 39.6 ± 19.5 38.7 ± 11.4 0.83 0.071
Body surface area (m²) 1.9 ± 0.2 1.9 ± 0.2 1.8 ± 0.2 1.7 ± 0.2 0.07 <0.001
Heart rate (beats/min) 60.6 ± 12.0 65.4 ± 15.7 69.9 ± 11.9 67.5 ± 12.1 0.47 0.005
Left heart variables
Septal WT (mm) 7.8 ± 1.3 7.6 ± 1.3 7.4 ± 1.2 7.6 ± 1.5 0.66 0.51
LV ED volume (ml/m²) 55.5 ± 13.6 56.7 ± 11.9 52.8 ± 13.3 56.8 ± 14.6 0.35 0.75
LV ES volume (ml/m²) 20.4 ± 7.1 18.0 ± 4.5 17.2 ± 5.1 18.4 ± 5.7 0.44 0.13
LV fractional shortening (%) 34.1 ± 5.3 37.8 ± 4.7 34.9 ± 4.4 37.5 ± 5.6 0.055 0.004
LV EF (%) 64.6 ± 6.9* 67.6 ± 5.6 68.0 ± 5.2 67.2 ± 4.0 0.55 0.030
GLS (%) 17.1 ± 3.1 19.3 ± 2.9 19.3 ± 1.9 20.9 ± 1.1 0.0003 <0.001
S’ LV lateral (cm/s) 8.0 ± 2.5 9.8 ± 1.9 11.1 ±2.6 10.6 ± 2.5 0.48 <0.001
E peak (cm/s) 71.3 ± 18.5 67.9 ± 12.8 76.3 ± 16.9 82.2 ± 13.6 0.17 0.013
E/E’ ratio 6.8 ± 2.9 5.9 ± 1.8 5.8 ± 1.5 5.5 ± 1.5 0.43 0.064
LA volume index (ml/m²) 26.2 ± 8.3 27.5 ± 6.8 23.3 ± 8.6 23.5 ± 6.4 0.94 0.18
Right heart variables
Minor RV echo criteria―no. 
(%)
2 (3) 0 (0) 0 (0) 0 (0)
Major RV echo criteria―no. 
(%)
34 (49) 0 (0) 0 (0) 0 (0)
RV ED area (cm²/m²) 13.3 ± 4.3 10.1 ± 1.8 9.9 ± 2.0 10.0 ± 1.7 0.86 <0.001
RV FAC (%) 39.9 ± 10.5 45.2 ± 7.1 51.7 ± 8.5 50.3 ± 6.5 0.28 <0.001
RVOT diameter (mm/m²) 18.5 ± 3.4 16.0 ± 2.3 16.5 ± 2.1 17.1 ± 2.4 0.39 0.002
TAPSE (mm) 20.3 ± 4.9 22.8 ± 3.4 21.6 ± 3.5 24.2 ± 2.8 0.004 0.001
RV S’ TDI (cm/s) 10.2 ± 2.7 12.2 ± 1.6 13.2 ±1.8 15.0 ± 2.1 0.009 <0.001
PASP (mmHg) 24.0 ± 4.7 24.8 ± 6.5 23.4 ± 4.4 22.3 ± 2.7 0.29 0.31
Global RV strain (%) 20.9 ± 7.2 29.0 ± 4.4 26.8 ± 5.1 31.0 ± 4.2 0.005 <0.001
WT = wall thickness, LV = left ventricular, ED = end-diastolic, ES = end-systolic, EF =
ejection fraction, GLS = global longitudinal strain, LA = left atrial, RV = right ventrcular, FAC
= fractional area change, RVOT = RV outflow tract, TAPSE = tricuspid antero-posterior
systolic excursion, TDI = tissue Doppler imaging, PASP = pulmonary artery systolic pressure.
* n=4 patients with LVEF <55%
Table 2: Multilayers LV GLS and RV regional strain analyses
Parameters
Group IV
(N=70)
Group III
(N=19)
Group II
(N=27)
Group I
(N=26)
p value
group II
vs I
p value
Anova
LV
Transmural LV GLS (%) 17.1 ± 3.1 19.1 ± 2.8 19.3 ± 1.8 20.9 ± 1.1 <0.001 <0.001
Endo LV GLS (%) 19.7 ± 3.6 22.3 ± 3.5 22.3 ± 2.0 24.3 ± 1.3 <0.001 <0.001
Epi LV GLS (%) 14.8 ± 2.8 16.7 ± 2.4 16.9 ± 1.8 18.4 ± 1.1 <0.001 <0.001
RV
Basal RV LS (%) 21.1 ± 9.0 29.6 ± 5.9 29.6 ± 6.4 30.8 ± 6.0 0.54 <0.001
Mid RV LS (%) 21.6 ± 9.0 30.7 ± 5.1 28.3 ± 6.0 32.2 ± 4.4 0.020 <0.001
Apical RV (%) 19.5 ± 6.6 26.0 ± 4.7 20.8 ± 5.7 29.9 ± 4.7 <0.001 <0.001
Endo = endocardial, Epi =epicardial, LV = left ventricular, GLS = global longitudinal strain,
RV = right ventricular, LS = longitudinal strain
Table 3: Intra- and interobserver mean percentage variability of LS analysis
Mean variability
LV strain
GLS
transmural
GLS
Endo
GLS
Epi
Regional LS
transmural
Regional
LS Endo
Regional
LS Epi
Intraobserver 3.4% 3.1% 4.6% 8.2% 7.8% 8.9%
Interobserver 4.2% 3.7% 6.1% 12.2% 12.8% 13.0%
Mean variability
RV strain
GLS
transmural
GLS
Endo
GLS
Epi
Regional LS
transmural
Regional
LS Endo
Regional
LS Epi
Intraobserver 8.3% 6.1% 9.8% 9.0% 7.7% 11.5%
Interobserver 11.8% 10.8% 11.9% 10.2% 9.7% 11.1%
LV=left ventricular, GLS=global longitudinal strain, Endo=endocardial, Epi=epicardial,
LS=longitudinal strain, RV=right ventricular.




